Not normally used: Pet scan can be used for evaluation of metastatic renal cancer. It is not currently recommended as a regularly scheduled test for follow-up according to the nccn. These guidelines are made by a group of experts in each cancer area.
Answered 6/7/2015
5.7k views
Sensitivity: Current literature estimates the sensitivity of f18-fdg for nodal metastatic renal cancer to be about 75% and declines to 50% after chemotherapy.
Answered 4/19/2014
5.7k views
FDG PET: Fdg pet has low sensitivity and specificity for renal cancers. Problems include variable uptake by tumors and excretion of tracer in the collecting system. Aggressive tumors are more likely to be glucose avid. Fdg pet can be helpful in identifying metastases. New tracers such as i-124 girentuximab and f-18 fluorothymidine may be more helpful in the future.
Answered 11/11/2015
4.7k views
A doctor has provided 1 answer
A doctor has provided 1 answer
12 doctors weighed in across 3 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question